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Table. 30-day MACE by procedure
Primary outcome Women Men P value
All CEA 4.09% (110/2689) 4.05% (155/3829) .9492
All CAS 7.18% (108/1504) 6.88% (158/2297) .7453
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nosis of vEDS presenting at two tertiary referral centers
from 2000 to 2012 were reviewed. Data collected
included demographics, family history, vascular pathology,
operative details, and outcomes. To replicate the pheno-
type-genotype correlation a second cohort was reviewed
using data from the Genetically Triggered Thoracic Aortic
Aneurysms and Cardiovascular Conditions Registry (Gen-
TAC), a National Institutes of Health-funded multicenter
database.
Results: A total of 62 cases (34% male, 75% with
positive family history, 15% HI) were identiﬁed. Arterial
aneurysms and dissections were seen in 38 (62%) cases.
Median age at initial vascular presentation was 41 (range
39-58) years in the HI group vs 33 (range 17-68) years in
MIS group. Aortic and mesenteric arterial involvement
was more common in the HI than MIS group (44% vs
15% and 44% vs 23%, respectively). The mortality was
0% in the HI group and 17% in the MIS group. The Gen-
TAC registry enrolled 103 cases (29% male, 55% with
positive family history, 6% HI). Median age at diagnosis
was 28 (range 1-63) years. Once again, aortic involve-
ment was more common in the HI vs MIS group (50%
vs 10%).
Conclusions: Aortic and mesenteric arterial involve-
ment in vEDS appears to be related to the underlying
mutation type, with the HI cases having milder disease
and later presentation. Molecular diagnosis is warranted
in vEDS cases as it predicts postoperative outcomes and
guides surveillance.
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hub: Nothing to disclose.Symptomatic CEA 5.91% (57/964) 5.39% (81/1502) .5910
Symptomatic CAS 8.31% (56/674) 9.47% (101/1067) .4402
Asymptomatic CEA 3.07% (53/1725) 3.18% (74/2327) .9274
Asymptomatic CAS 6.27% (52/830) 4.63% (57/1230) .1092
All Symptomatic 6.90% (113/1638) 7.08% (182/2569) .8527
All Asymptomatic 4.11% (105/2555) 3.68% (131/3557) .4194S3: SVS Plenary Session III
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Objectives: While optimal treatment of carotid
stenosis remains unclear, available data suggest that women
have higher risk of adverse events after carotid revasculari-
zation. SVS-VR data was used to determine the impact of
gender after CEA and CAS.
Methods: 10,319 patients (41% women) underwent
CEA (6518) and CAS (3801). The primary end pointwas a composite of death, stroke and myocardial infarction
(MACE) at 30-days. The effect of symptom status and
gender on outcomes was also analyzed.
Results: There was no difference in age between
genders, but men were more likely to be symptomatic
(41% v 39%). Women were more likely to have hyperten-
sion and COPD while men had a higher prevalence of
CAD and smoking history. For disease etiology in CAS,
restenosis was more common in women (28% v 21%)
while radiation was higher in men (7% vs 3%). MACE
was lower for CEA in all patient groups in both genders
(P < .05 for all comparisons between CEA and CAS).
Comparing women and men (Table), there were no
statistically signiﬁcant differences in MACE for either
CEA (4% vs 4%) or CAS (7% vs 7%), which remained
even after stratiﬁcation by symptomatology and multivar-
iate risk adjustment.
Conclusions: In this large, real-world analysis, women
and men demonstrated similar results after CEA or CAS.
These data suggest that, contrary to previous reports,
women derive similar beneﬁts as men from carotid revascu-
larization. However, CAS is associated with inferior
outcomes compared to CEA for both women and men,
regardless of symptom status.
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Objectives: To determine the association between
progression of internal carotid artery stenosis and subse-
quent ipsilateral cerebral ischemic events (AF, TIA or
stroke) in the Asymptomatic Carotid Stenosis and Risk of
Stroke (ACSRS) Study.
Methods: 1121 patients with asymptomatic carotid
stenosis 50-99% in relation to the bulb diameter were
followed-up 6-monthly clinically and with carotid duplex
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tion of velocities and velocity ratios, including PSVic/
EDVcc, into six groups: 50%-60%, 60%-70%, 70%-80%,
80%-90%, 90%-95% or 95%-99%. Progression or regression
was considered present if there was a change to adjacent
groups that persisted for at least two consecutive visits.
Results: Regression occurred in 43 (3.8%), no change
in 856 (76.4%), progression in 190 (17.0%) and occlusion
in 32 (2.8%) patients. Ipsilateral ischemic event rate was 0%
with regression, 10.3% with no change, 17.4% with
progression and 28.1% with occlusion (c2, P < .001).
The corresponding values for stroke were 0%, 4.7%. 7.9%
and 12.5%, respectively (c2, P ¼ .029).
Using Kaplan-Meier curves, in the subgroup of patients
with stenosis 70-95% the average annual ipsilateral ischemic
event rate was 2.25% in patients with regression or absence
of change and 4.75% in patients with progression (P <
.001; OR, 2.15, 95% CI, 1.44-3.21). The corresponding
values for stroke were 1.12% and 2.50% (P ¼ .025; OR,
2.01, 95% CI, 1.14-3.54). In the subgroup of occlusion
the average annual ipsilateral ischemic event rate was
5.6% and for stroke 2.6%.
In a logistic regression analysis, the severity of the ﬁnal
stenosis (P ¼ .005; OR, 1.28; 95% CI, 1.08-1.53) and
progression (P ¼ .034; OR, 1.47; 95% CI, 1.03-2.10)
were both independent predictors of ipsilateral ischemic
events.
Conclusions: The degree of stenosis and progression
are both associated with the occurrence of ischemic events
and stroke. Progression identiﬁes a group at increased risk
of stroke.
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Objectives: Although level-1 evidence supports
carotid endarterectomy (CEA) for stroke prevention in
patients with asymptomatic severe (>70%) carotid stenosis
(ASCAS), medical therapy has been promulgated by some
as equally effective. The goal of this study is to determine
the natural history of medically treated ASCAS.
Methods: Patients with ASCAS were identiﬁed by
Duplex (index study 2005-06) and included if they were
treated with medical therapy (for comorbidities or patient
preference). Patients were excluded if they had a carotid
intervention within 6 months of the index Duplex. Aspirin
and statin use (including LDL) was recorded for each
patient. The mean follow-up was 52 months. Study
endpoints included: ipsilateral neurologic symptoms (INS)
(stroke/tia) and death.Results: There were 126 carotid arteries in 115pts. 88
(70%) had severe (70%-89%) and 38 (30%) had very severe
(90%-99%) stenoses (VSS). Demographics: age 73.5 years,
5% chronic kidney disease (CKD), 86% were on statins
(28% had LDL <100 mg/dL) and 88% were on aspirin.
31 (25%) patients developed INS during follow-up and
most 23/31 (74%) occurred within 12 months of the initial
DUS; 45% of INS were strokes. The 5-year actuarial
freedom from INS was 70.1%+/5%. Multivariate predic-
tors of INS included: VSS (HR, 3.23; CI, 1.56-6.76; P ¼
.002), CKD (HR, 6.25; CI, 2.05-19.2; P ¼ .001), age
(HR, .94; CI, .91-0.98; P ¼ .001). 41 (33%) patients
underwent eventual carotid revascularization (32 CEA, 9
Stent); 56% were performed for INS and 44% for plaque
progression. The 5-year actuarial survival was 69.8%+/
4.1%. Multivariate predictors of death included: Age
(HR, 1.06; CI, 1.03-1.1; P ¼ .0001), COPD (HR, 1.92;
CI, 1.08-3.41; P ¼ .03) and DM (HR, 5.08; CI, 2.86-
9.01; P < .0001). Neither statin nor aspirin use was protec-
tive in this cohort.
Conclusions: Medically managed patients with
ASCAS develop INS early; especially those with >90%
stenosis. The natural history of medically treated ASCAS
and failure of aspirin/statins to prevent INS supports
the continued role of CEA as ﬁrst line therapy in these
patients.
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Video Presentation
Novel Carotid Reconstruction Technique
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Background: To demonstrate a novel and simple
Carotid Endarterectomy technique that results in a shorter
procedure, decreased recovery time, lesser risk of complica-
tions and signiﬁcant cost reduction.
Technical Description: This procedure consists of
a mini arteriotomy (12 to 14 mm long) on the front
wall of the internal carotid’s widest origin “without”
transecting the artery completely as in the classical ever-
sion technique.
Eversion endarterectomy is done from below the bifur-
cation distally into the external and internal simultaneously.
There are several advantages:
a. The back wall of the artery remains intact, therefore
less chances of suture line proliferation or recurrence.
b. Easy to prolong arteriotomy and correct a question-
able distal endpoint (contrary to the standard
complete transection)
c. Avoid prosthetic patch preventing infection, pseudoa-
neurysm, or suture line bleeding
d. Signiﬁcant reduced clamping time
e. Considerable reduction in the cost of OR time, anes-
thesia, PACU, and LOS
